News

We’re proud to support Sempre Health to advance its mission of reducing medication costs and improving member adherence for patients with chronic disease.

What makes Echo Health Ventures different from other corporate venture partners is that we invest under a dual mandate to drive both strategic impact and financial returns.

At Echo, we partner with innovative companies working to transform the health care industry and help them build relationships to deliver sustainable, impactful market solutions.

DispatchHealth today announced its refined market strategy, as reflected on its refreshed company website.

Anurati Mathur, co-founder and CEO of Echo portfolio company Sempre Health, discussed Sempre’s success in medication adherence on the most recent episode of the Regence HealthChangers podcast. 

TytoCare, pioneer of remote physical examination technology featuring FDA-cleared medical devices, today announced two major developments: the appointment of Adam Pellegrini as Chief Executive Officer, and the closing of a $25 million-plus growth round led by Insight Partners.

Anurati Mathur, co-founder and CEO of Echo portfolio company Sempre Health, discussed Sempre’s success in medication adherence on the most recent episode of the Regence HealthChangers podcast. 

Echo Health Ventures CEO Rob Coppedge was recently recognized by Global Corporate Venturing (GCV) on its list of GCV Titans, leaders who have been the head of their investment unit for at least a decade. In profiling Coppedge, GCV took a long look at the history of Echo, which is celebrating its 10th anniversary this year. 

Read our 2025 Impact Report to learn how Echo, alongside our industry partners, drove sustainable impact in health care over the last year.